HOME >> BIOLOGY >> NEWS
Perchlorate found in dairy and breast milk samples from across the country

In a new study of breast milk and store-bought milk from across the United States, scientists at Texas Tech University found perchlorate in every sample but one. The results suggest that this thyroid-disrupting chemical may be more widespread than previously believed.

The report was published Feb. 22 on the Web site of Environmental Science & Technology, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society.

Perchlorate occurs naturally and is also a primary ingredient in solid rocket fuel. The chemical, which has been showing up in many segments of the environment, can interfere with iodide uptake in the thyroid gland, disrupting adult metabolism and childhood development.

The researchers, led by Professor Purnendu Dasgupta, Ph.D., of the university's department of chemistry and biochemistry, analyzed 47 dairy milk samples purchased randomly from grocery stores in 11 states, and 36 breast milk samples from women recruited at random in 18 states. Every sample of breast milk contained perchlorate, and only one sample of dairy milk contained no detectable levels.

The average perchlorate concentration in breast milk was 10.5 micrograms per liter; the dairy milk average was 2.0 micrograms per liter. No definitive national standard exists, although the U.S. Environmental Protection Agency had suggested a limit of 1.0 micrograms per liter in drinking water.

The researchers also found that high levels of perchlorate correlated with low levels of iodide in breast milk, which can inhibit thyroid function in nursing womenan essential component for proper neural development of the fetus. Although the data are limited, the levels of iodide in this study are sufficiently low to be of concern, according to the researchers. They suggest that the recommended daily intake of iodine for pregnant and nursing women may need to be revised upwards.

The American Chemical Society is a nonprofi
'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
22-Feb-2005


Page: 1 2

Related biology news :

1. Waters off Washington state only second place in world where glass sponge reefs found
2. First new multiple sclerosis gene found in 30 years
3. Obesity found to be a risk factor for multiple myeloma
4. Antibody-altering protein found in developing B cells
5. New use for a cell toxin found to inhibit survival proteins in cancer cells
6. New way to target and kill antibiotic-resistant bacteria found
7. Soil particles found to boost prions capacity to infect
8. Support for chromosomal theory of cancer found in cancers development of drug resistance
9. Massive herds of animals found to still exist in Southern Sudan
10. Origins of nervous system found in genes of sea sponge, report scientists at UC Santa Barbara
11. Origins of nervous system found in genes of sea sponge

Post Your Comments:
(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
Cached News: